R Michael Hofmann
Overview
Explore the profile of R Michael Hofmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
247
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coscia L, Cohen D, Dube G, Hofmann R, Moritz M, Gattis S, et al.
Transplantation
. 2023 Jun;
107(9):2047-2054.
PMID: 37287109
Background: Posttransplant fertility returns quickly, and female recipients of child-bearing age may conceive while on immunosuppression. However, pregnancy after transplantation confers risks to the recipient, transplant, and fetus, including gestational...
2.
Combs J, Kagan A, Boelkins M, Coscia L, Moritz M, Hofmann R
Am J Transplant
. 2018 May;
18(8):2079-2082.
PMID: 29719109
Impaired fertility is common among patients with chronic organ failure, including end-stage renal disease (ESRD). Women of childbearing age undergoing transplantation may experience rapid return of fertility. Pregnancy posttransplant presents...
3.
Medow J, Sanghvi S, Hofmann R
Clin Med Res
. 2014 Dec;
13(2):89-93.
PMID: 25487240
Traumatic brain injury and intracranial hypertension often require treatment to optimize patient outcome. There are a variety of complex medical conditions that can preclude standard approaches to the treatment of...
4.
Lee B, Gabardi S, Grafals M, Hofmann R, Akalin E, Aljanabi A, et al.
Clin J Am Soc Nephrol
. 2014 Feb;
9(3):583-9.
PMID: 24482066
Background And Objectives: BK virus reactivation in kidney transplant recipients can lead to progressive allograft injury. Reduction of immunosuppression remains the cornerstone of treatment for active BK infection. Fluoroquinolone antibiotics...
5.
Valliant A, Hofmann R
Int J Nanomedicine
. 2013 Sep;
8:3297-307.
PMID: 24023516
Anemia in chronic kidney disease is a prevalent and expensive problem in the United States, and it is well documented that anemia worsens as glomerular filtration rates decline. The complications...
6.
Astor B, Muth B, Kaufman D, Pirsch J, Hofmann R, Djamali A
Kidney Int
. 2013 May;
84(4):810-7.
PMID: 23657143
Serum β(2)-microglobulin (β(2)M), a novel marker of kidney function, predicts mortality and kidney failure in the general population, and its elevation following transplantation is a marker of acute rejection. The...
7.
Djamali A, Muth B, Ellis T, Mohamed M, Fernandez L, Miller K, et al.
Kidney Int
. 2013 Mar;
83(6):1185-92.
PMID: 23447068
In order to define the intensity of immunosuppression, we examined risk factors for acute rejection in desensitization protocols that use baseline donor-specific antibody levels measured as mean fluorescence intensity (MFImax)....
8.
Mohamed M, Muth B, Vidyasagar V, Foley D, Fernandez L, Hofmann R, et al.
Clin Transpl
. 2012 Jul;
:389-94.
PMID: 22755436
We examined whether changes in posttransplant highest intensity donor specific anti-HLA antibody specificity (DSAmax) measured by single antigen bead via Luminex (One Lambda, Inc.) were associated with antibody-mediated rejection (AMR)....
9.
Hofmann R
Adv Chronic Kidney Dis
. 2012 May;
19(3):142-8.
PMID: 22578673
Acute kidney injury (AKI) affects approximately 5% of all hospitalized patients, and its incidence continues to increase. The treatment of AKI involves tremendous financial costs, estimated to exceed $10 billion...
10.
LaMattina J, Mezrich J, Hofmann R, Foley D, DAlessandro A, Sollinger H, et al.
Transpl Int
. 2012 Mar;
25(5):518-26.
PMID: 22394259
Between 1 January 2002 and 31 December 2007, our center performed 1687 adult renal transplants. A retrospective analysis was performed to compare outcomes between patients receiving alemtuzumab (n = 632)...